|
VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2 |
|
CIGB-258 at COVID-19 |
|
PrevengHo-Vir Homeoprohylaxis COVID-2019 |
|
Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab |
|
Biomodulina T - IM- covid-19 - older adultos - Phase IV clinical trial |
|
Therapy for COVID-19-Phase I-II |
|
Pharmacodynamics of the Nasalferon in healthy volunteers. |
|
ESPERANZA study |
|
CIGB 2020 in contacts and SARS-CoV-2 infection suspects |
|
EGF in bilateral symmetric diabetic neuropathy |
|
Enhanced recovery protocols in cardiac surgery protocols |
|
Mindfulness and development of well-being in the couple relationship experience of young adults: A protocol of a randomized controlled trial |
|
Effect of beef consumption on lipid metabolism |
|
Efficacy of nasal provocation test with VALERGEN-DP, DS and BT |
|
COURAGE-2 Study |
|
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer |
|
VALERGEN-combination of routes- Asthma-Adults-Phase II |
|
Melagenina Plus - Vitiligo – phase IV |
|
Combifer T, Trofin and Ferrous Fumarate in iron-deficiency anemia in pregnant women. |
|
Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT) |
